The global duodenoscope market size was reached at USD 91.48 billion in 2022 and is expected to hit around USD 207.6 billion by 2032, poised to grow at a CAGR of 8.54% during the forecast period from 2023 to 2032.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
Duodenoscopes are flexible, hollow, lighted tubes that help doctors to view the top of a patient’s duodenum or intestine. Doctors use duodenoscopes for endoscopic retrograde cholangiopancreatography (ERCP) procedures. This device supports doctors in diagnosing and treating severe life-threatening diseases like cancer and gallstones in the bile ducts and pancreas. As per the U.S. Food and Drug Administration, Americans undergo over 500,000 ERCP procedures every year using duodenoscopes.
Duodenoscopes are helpful in diagnosing infection, tumors, trauma, and cancer of the bile ducts. This device is also useful in the treatment of Chronic pancreatitis, Acute pancreatitis (inflammation of the pancreas), Pancreatic pseudocysts (fluid-filled sac in the abdomen), and cancers of the pancreas.
Duodenoscope is a more complex instrument when compared with other endoscopes. Cleaning and disinfecting a duodenoscope is a bit tough. The duodenoscopes market is expanding considerably owing to the rising prevalence of numerous gastrointestinal conditions such as bile duct and pancreatic cancer tumors. Additionally, growing research and development (R&D), technological advancements to recognize the risk factors related to the transmission of infectious agents, and increasing awareness is driving the duodenoscope market growth during the review period.
Our duodenoscope report aims to give an overview of the market with exhaustive market segmentation by product type, application, and end-user. The duodenoscope market is estimated to experience remarkable growth during the study period. This report provides crucial data & statistics relevant to the market considering the leading players, market trends, and key opportunities.
| Report Coverage | Details |
| Market Size in 2023 | USD 99.29 Billion |
| Market Size by 2032 | USD 207.6 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 8.54% |
| Largest Market | North America |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | By Product Type, By Application and By End User |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America and Middle East & Africa |
Considering the qualitative and quantitative facts, our duodenoscope market report includes a detailed overview of the current market situation. Various doctors and clinicians have started using duodenoscope for effective diagnosis and treatment of respective disorders and diseases.
The launch of distinct product variants is supporting the market growth from the supply side. The Ambu duodenoscope is honored with Breakthrough Device Designation from the FDA. The Ambu® aScope™ Duodeno is a completely disposable and single-use duodenoscope useful for respective ERCP procedures.
In December 2019, the FDA approved the 1st completely disposable duodenoscope that was manufactured by Boston Scientific Corporation. Such approvals from the respective government authorities support the market growth substantially.
In August 2021, Al Jalila Foundation raised AED220 million ($59.88 million) for the Hamdan Bin Rashid Cancer Charity Hospital. This hospital accepts patients from anywhere in the United Arab Emirates (UAE) and all services will either be highly subsidized or free of charge. Such initiatives encourage the adoption of duodenoscope for respective cancer treatments and support the market growth in the Middle East region.
Upper endoscopy (also known as esophagogastroduodenoscopy or EGD) is the most often conducted test if the doctor feels the chances of stomach cancer. The American Cancer Society’s estimates for gastric cancer (also known as stomach cancer) in the US indicate around 26,500 new cases for 2023 (10,570 in women and 15,930 in men). For 2023, the American Cancer Society also predicts approximately 11,130 deaths from stomach cancer (4,440 women and 6,690 men). Such serious estimates enhance the demand for duodenoscope across the United States in near future.
The switching costs in this market are very uncertain, which reduces the bargaining power of duodenoscope buyers. Owing to the small count of duodenoscope manufacturers and a large count of duodenoscope purchasers, the bargaining power of buyers is less as compared to the bargaining power of suppliers.
COVID-19 Impact:
The pandemic of COVID-19 has impacted the duodenoscope market considerably. The adverse impact was majorly because of the reduction in endoscopy procedures during the initial stages of the pandemic. Since transport was largely affected in many parts of the world, the export of various essential components needed for the duodenoscope was severely impacted. Thus, the supply side of the duodenoscope market was hampered considerably owing to numerous limitations.
Among the endoscopy procedures, duodenoscopes involved a high risk of nosocomial infections. While single-use duodenoscopes had a certain utility for COVID-19-positive patients, there were availability and cost-related constraints across many countries of the world. During the COVID-19 pandemic period, ERCPs volumes reduced notably by 57% as compared to the pre-pandemic period. Such a decrease in the ERCPs volumes had a remarkable impact on the growth of the duodenoscope market.
Based on product type, the global duodenoscope market is bifurcated into Flexible Video Dueodenoscopes and Flexible Non-Video Dueodenoscopes. The Flexible Video Dueodenoscopes segment is expected to hold a significant market share during the forecast period.
Earlier used duodenoscopes included flexible non-video (fibre) duodenoscopes. During the initial stage, fiber duodenoscopes were used the most. But now, the use of non-video duodenoscopes is declining and they can even become obsolete very soon.
Flexible video duodenoscopes include a flexible insertion tube that features video recording functionality. This flexible insertion tube uses a charge-coupled device for displaying magnified images on the video screen. Now, the flexible video duodenoscope segment is dominating with a higher market share. Olympus Corporation is one of the leading players in the duodenoscopes market followed by Fujifilm Holding, Karl Storz, and Pentax.
Based on application, the global duodenoscope market is segmented into diagnosis and treatment. The diagnosis segment had the highest revenue share in 2022. The diagnosis segment is expected to dominate the market during the study period.
A duodenoscope is useful for diagnosis as well as treatment of numerous conditions of the biliary tree and pancreas, including stones, ductal obstructions, and malignancy.
A diagnostic duodenoscope (JF-140R, Olympus) with a working channel of 3.2 mm and an outer diameter of 11 mm can be used for children aged 1–3 years. A therapeutic duodenoscope having a 4.2 mm working channel can be used for ERCP among elder children.
In 2022, North America region held the largest revenue share in the duodenoscope market. North America is the most developed continent owing to the presence of nations with favorable healthcare policies, high spending capacity, and early adoption of the latest medical technologies. In the United States, the per-procedure cost of a disposable duodenoscope varies from $797 to $1,547. This cost is for centers that perform at the 75th percentile of ERCP procedure volume.
In 2022, health research expenditures in the private sector in Canada reached about $1,354.56 million. This was a significant rise from the amount of $1,276.01 million spent during 2021. A remarkable rise in health expenditure enhances the scope for new duodenoscope in the North American region.
In the Asia Pacific (APAC) region, pancreatic cancer is considered to be one of the most aggressive types of cancer. In India, pancreatic cancer is the 11th most prevalent kind of cancer. In 2019, the count of pancreatic cancer cases in China was around 114,964, and the incidence was found to be 5.78/100,000. Owing to such a count of pancreatic cancer cases, the need for duodenoscopes is anticipated to rise drastically in the Asia Pacific (APAC) region in the coming years.
Various Gulf countries such as Kuwait, Bahrain, Qatar, Oman, the United Arab Emirates (UAE), and the Kingdom of Saudi Arabia (KSA) have well-developed infrastructure required for duodenoscopes. The duodenoscope market in the Middle East region is anticipated to grow promisingly during the study period.
Due to low literacy, civil war, and uncertainty in some African countries, the adoption of duodenoscopes in the African region is expected to take place at a comparatively slow rate. The awareness about the benefits of duodenoscope is increasing in the Latin America region. The duodenoscope market in the Latin America region is expected to grow gradually.
Segments Covered in the Report:
By Product Type
By Application
By End User
By Geography
PROCEED TO BUY :
ASK FOR SAMPLE
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
